Europe Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
The Europe blood plasma derivatives market was valued at US$ 8,474.00 million in 2022 and is projected to reach US$ 14,262.27 million by 2028; it is expected to grow at a CAGR of 9.1% from 2022 to 2028.
Rise in Geriatric Population is Driving the Europe Blood Plasma Derivatives Market
The elderly population is rising across the world. Three groups of hematological neoplastic disorders, including multiple myeloma, acute myeloid leukemia, and chronic lymphatic leukemia, increase with age. Multiple myeloma is cancer related to blood plasma and mainly affects the elderly. As per the Global Ageing 2019 survey, the population of people aged 65 and above across the world was 703 million in 2019. Furthermore, the elderly population is expected to double to 1.5 billion by 2050. According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Furthermore, the United Nations World Population Ageing 2017 report states 962 million people worldwide were aged 60 or above in 2017, and the number is expected to reach ~2.1 billion by 2050. Moreover, according to Eurostat, there were 101.1 million elderly in the EU-28 at the start of 2018, accounting for about one-fifth (19.7%) of the overall population. The number of older people in the European Union (EU) is expected to rise steadily over the next three decades, culminating at 149.2 million by 2050; their relative share of the total population is expected to increase gradually, reaching 28.5 % by 2050.
One of the most recognized consequences of aging is a weak immune system. For people aged 65 and above, plasma therapy is the most successful therapy to treat multiple physiological disorders. Aging can cause changes in the blood marrow. Thus, there is an increased risk of developing cardiovascular, neurological, and blood-related disorders. Therefore, the rise in the prevalence of such disorders among geriatric populations is fueling the growth of the blood plasma derivatives market.
Europe Blood Plasma Derivatives Market Overview
The Europe blood plasma derivatives market has been segmented into Germany, France, Italy, Spain, the United Kingdom, and Rest of Europe. Germany is expected to account for the largest market share and is expected to develop moderately in Europe. Europe is the second-largest market for blood plasma derivatives. As indicated by the diary of BMC Infectious Disease, in November 2021, it was accounted for that the healing plasma treatment is utilized for the patient contaminated with COVID-19. The Meta - investigation clinical preliminary led to breaking down the proficiency and adequacy of recuperating plasma. The outcome shows a decline in the death rate in COVID-19 patients by gaining strength in plasma treatment. Additionally, the flood in the number of R&D exercises and the rising government subsidizing will add to the territorial development. For instance, in August 2020, Kedrion Biopharma (Italy) began improving a plasma-inferred treatment for treating COVID-19 infection that could make it accessible to patients in just three to a half year. In May 2020, the European Blood Alliance (EBA) combined efforts with the European Commission, comprising DG SANTE, DG CNECT, and DG DIGIT. This association assisted with working and dealing with an EU-wide, open-access stage that assembles information on the COVID-19 gaining strength plasma treatment.
Furthermore, as per World Health Organization (WHO), out of 250,000 individuals diagnosed with PID (primary immune deficiencies) in the US in 2017, roughly 125,000 get month-to-month mixtures of immunoglobulins. It is assessed that more than 300,000 patients get monthly-to-month immunoglobulins implantations for PID. The rise in chronic conditions and increasing demand for immunoglobulin drive the development of the blood plasma derivatives market.
Europe Blood plasma derivatives Market Revenue and Forecast to 2028 (US$ Million)
Europe Blood plasma derivatives Market Segmentation
The Europe blood plasma derivatives market is segmented into type, application, end user, and country.
The Europe blood plasma derivatives market, by type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held a larger market share in 2022.
Based on application, the Europe blood plasma derivatives market is divided into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand disease, and other applications. The immunodeficiency diseases applications segment held the largest share of the market in 2022.
The blood plasma derivatives market, by end user, is segmented into hospitals, diagnostic laboratories, clinics, and other end users. The hospitals segment held the largest share of the market in 2022.
Based on country, the Europe blood plasma derivatives market is segmented into Germany, France, UK, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.
Grifols SA; SK Plasma Co Ltd; Octapharma AG; Monobind Inc.; Intas Pharmaceuticals Ltd; Takeda Pharmaceutical Co Ltd; CSL Behring LLC; LFB SA; Kedrion SpA; and Fusion Health Care Pvt Ltd are the leading companies operating in the Europe blood plasma derivatives market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Blood Plasma Derivatives Market – by Type
1.3.2 Europe Blood Plasma Derivatives Market – by Application
1.3.3 Europe Blood Plasma Derivatives Market – by End User
1.3.4 Europe Blood Plasma Derivatives Market – by Country
2. Europe Blood Plasma Derivatives Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Blood Plasma Derivatives Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert’s Opinion
5. Europe Blood Plasma Derivatives Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. Blood Plasma Derivatives Market – Europe Analysis
6.1 Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Europe Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Blood Plasma Derivatives Market Analysis and Forecasts to 2028 – by Application
8.1 Overview
8.2 Europe Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Europe Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 Europe: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 Germany: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.1.4 Germany: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.1.5 Germany Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 France: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 France: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.2.4 France: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.2.5 France Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Italy: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 Italy: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.3.4 Italy: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.3.5 Italy Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.4 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Spain: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.4.3.1 Spain: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.4.4 Spain: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.4.5 Spain Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.5 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 United Kingdom: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.5.3.1 United Kingdom: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.5.4 United Kingdom: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.5.5 United Kingdom Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.1.6 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.1.6.3.1 Rest of Europe: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.1.6.5 Rest of Europe Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Blood Plasma Derivatives Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Grifols SA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 SK Plasma Co Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Monobind Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Intas Pharmaceuticals Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Fusion Health Care Pvt Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Takeda Pharmaceutical Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CSL Behring LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 LFB SA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Kedrion SpA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. France Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. France Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. France Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. France Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Italy Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. United Kingdom Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. United Kingdom Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 19. United Kingdom Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. United Kingdom Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market
Table 26. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market
Table 27. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Blood Plasma Derivatives Market Segmentation
Figure 2. Europe Blood Plasma Derivatives Market, by Country
Figure 3. Europe Blood Plasma Derivatives Market Overview
Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in Europe Blood Plasma Derivatives Market
Figure 5. Germany is Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Europe Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
Figure 11. Albumin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Factor VIII: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Factor IX: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Immunoglobulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. IgG: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. IgM: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. IgA: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. IgD: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. IgE: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hyperimmune Globulin: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
Figure 23. Hemophilia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Hypogammaglobulinemia: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immunodeficiency Diseases: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Von Willebrand Disease: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other Applications: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
Figure 29. Hospitals: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Clinics: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Other End Users: Europe Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Growth Strategies in the Blood Plasma Derivatives Market
- Grifols SA
- SK Plasma Co Ltd
- Octapharma AG
- Monobind Inc.
- Intas Pharmaceuticals Ltd
- Takeda Pharmaceutical Co Ltd
- CSL Behring LLC
- LFB SA
- Kedrion SpA
- Fusion Health Care Pvt Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe blood plasma derivatives market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe blood plasma derivatives market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the blood plasma derivatives market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution